Goldilocks, vitamin D and sarcoidosis

Arthritis Research and Therapy

Volumn 16, Issue 3, 2014, Pages

  Baughman, Robert P ^a,b   Lower, Elyse E ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 ALPHA HYDROXYLASE; 25 HYDROXYVITAMIN D; CORTICOSTEROID; ERGOCALCITROL; OXYGENASE; UNCLASSIFIED DRUG; VITAMIN D;

BONE FRAGILITY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EDITORIAL; ENZYME ACTIVITY; FRACTURE; FRAGILITY FRACTURE; HIGH RISK PATIENT; HUMAN; HYPERCALCEMIA; HYPERCALCIURIA; KIDNEY FAILURE; LUNG SARCOIDOSIS; OSTEOPOROSIS; RISK REDUCTION; SARCOIDOSIS; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; CALCIUM METABOLISM DISORDERS; COMPLICATION; FEMALE; HUMANS; MALE; METABOLISM; SPINAL FRACTURES;

CALCIUM METABOLISM DISORDERS; FEMALE; HUMANS; MALE; SARCOIDOSIS; SPINAL FRACTURES;

EID: 84901357681     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4568     Document Type: Editorial

References (10)

1. Saidenberg-Kermanac'h N, Semerano L, Nunes H, Sadoun D, Guillot X, Boubaya M, Naggara N, Valeyre D, Boissier MC. Bone fragility in sarcoidosis and relationships with calcium metabolism disorders: a cross sectional study of 142 patients. Arthritis Res Ther 2014, 16:R78. 10.1186/ar4519, 24655357.
2. Kavathia D, Buckley JD, Rao D, Rybicki B, Burke R. Elevated 1,25-dihydroxyvitamin D levels are associated with protracted treatment in sarcoidosis. Respir Med 2010, 104:564-570. 10.1016/j.rmed.2009.12.004, 20071158.
3. Baughman RP, Janovcik J, Ray M, Sweiss N, Lower EE. Calcium and vitamin D metabolism in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2013, 30:113-120.
4. Mahévas M, Lescure FX, Boffa JJ, Delastour V, Belenfant X, Chapelon C, Cordonnier C, Makdassi R, Piette JC, Naccache JM, Cadranel J, Duhaut P, Choukroun G, Ducroix JP, Valeyre D. Renal sarcoidosis: clinical, laboratory, and histologic presentation and outcome in 47 patients. Medicine (Baltimore) 2009, 88:98-106.
5. Lavender TW, Martineau AR, Quinton R, Schwab U. Severe hypercalcaemia following vitamin D replacement for tuberculosis-associated hypovitaminosis D. Int J Tuberc Lung Dis 2012, 16:140. 10.5588/ijtld.11.0368, 22236861.
6. Rizzato G, Montemurro L. Reversibility of exogenous corticosteroid-induced bone loss. Eur Respir J 1993, 6:116-119.
7. Adler RA, Funkhouser HL, Petkov VI, Berger MM. Glucocorticoid-induced osteoporosis in patients with sarcoidosis. Am J Med Sci 2003, 325:1-6. 10.1097/00000441-200301000-00001, 12544077.
8. Grossman JM, Gordon R, Ranganath VK, Deal C, Caplan L, Chen W, Curtis JR, Furst DE, McMahon M, Patkar NM, Volkmann E, Saag KG. American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res (Hoboken) 2010, 62:1515-1526.
9. Sweiss NJ, Lower EE, Korsten P, Niewold TB, Favus MJ, Baughman RP. Bone health issues in sarcoidosis. Curr Rheumatol Rep 2011, 13:265-272. 10.1007/s11926-011-0170-1, 3311464, 21327743.
10. Sanders KM, Stuart AL, Williamson EJ, Simpson JA, Kotowicz MA, Young D, Nicholson GC. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 2010, 303:1815-1822. 10.1001/jama.2010.594, 20460620.